Effectiveness of Pain Science Education in People With Symptomatic Knee Osteoarthritis
Launched by MARMARA UNIVERSITY · Dec 6, 2022
Trial Information
Current as of January 21, 2025
Completed
Keywords
ClinConnect Summary
Contemporary pain science education provides a scientific basis for the increased sensitivity produced in chronic pain due to adaptations in the central nervous system. In the literature, pain science education has been shown to reduce unhelpful pain beliefs and improve pain, function, and disability in several chronic musculoskeletal pain states, but data specific to knee OA are lacking.
Patients with knee osteoarthritis who meet the inclusion criteria and agree to participate in the study will be included. The participants will be randomly divided into two groups. These groups are: a) in...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having been diagnosed with knee osteoarthritis according to the criteria of the American College of Rheumatology (ACR).
- • Being between the ages of 45-65
- • Having knee pain lasting at least 6 months
- • Average knee pain intensity of ≥4 on 11- point numeric rating scale in the past week
- • Having Turkish as mother tongue
- • Being literate
- Exclusion Criteria:
- • Having health problems (eg heart or lung disease) that prevent safe participation in physical activity interventions as listed in the American College of Sports Medicine Guidelines.
- • Neurological disorders affecting the lower extremity (eg multiple sclerosis or stroke)
- • Using an assistive device
- • Being diagnosed with OA in joint areas other than the knee joint
- • Presence of inflammatory arthritis (including rheumatoid arthritis)
- • Presence of any condition that affects decision making/memory (eg Alzheimer's, dementia)
- • Knee replacement/surgery planning for the next 3 months
Trial Officials
Hilal Ata Tay
Principal Investigator
Marmara University
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Istanbul, Maltepe, Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials